Febit has launched Hybselector, an instrument for high-throughput targeted re-sequencing, at the recent Advances in Genome Biology and Technology meeting.
The compact Hybselector instrument will replace the Geniom RT Analyzer for high-quality DNA enrichment followed by targeted next-generation sequencing.
It features all the technical components necessary for Hybselect, Febit's DNA enrichment protocol.
The company said that the economic benefit of Hybselect increases the potential for widespread use of next-generation sequencing in clinical studies.
Instead of sequencing the complete genomes of only a limited number of patients, Hybselect enables the analysis of specific genes of interest from large patient cohorts for the same price and data-management effort.
The larger patient pool now provides the statistically relevant data necessary for clinical studies.
